Working with TipRanks
Follow Us
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
Kala Pharmaceuticals Inc (KALA)
NASDAQ:KALA
RESEARCH TOOLSreports
Kala Pharmaceuticals (KALA) Stock Price & Analysis
1,417 Followers
KALA Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$3.54 - $56.72
Previous Close$10.34
Volume2.93K
Average Volume (3M)39.85K
Market Cap
$26.30M
Enterprise ValueN/A
Total Cash (Recent Filing)$59.18M
Total Debt (Recent Filing)$33.57M
Price to Earnings (P/E)-0.5
Beta-0.65
Next Earnings
Nov 09, 2023EPS Estimate
-$3.46Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-19.91
Shares Outstanding2,542,716
10 Day Avg. Volume25,688
30 Day Avg. Volume39,855
Standard Deviation0.86
R-Squared0.00901
Alpha0.06
Financial Highlights & Ratios
Price to Book (P/B)1.55
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-0.90
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.00
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda0.00
Forecast
1Y Price Target
$31.50Price Target Upside204.52% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Kala Pharmaceuticals News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
KALA FAQ
What was Kala Pharmaceuticals Inc’s price range in the past 12 months?
Kala Pharmaceuticals Inc lowest stock price was $3.54 and its highest was $56.72 in the past 12 months.
What is Kala Pharmaceuticals Inc’s market cap?
Currently, no data Available
When is Kala Pharmaceuticals Inc’s upcoming earnings report date?
Kala Pharmaceuticals Inc’s upcoming earnings report date is Nov 09, 2023 which is in 47 days.
How were Kala Pharmaceuticals Inc’s earnings last quarter?
Kala Pharmaceuticals Inc released its earnings results on Aug 04, 2023. The company reported -$4.36 earnings per share for the quarter, missing the consensus estimate of -$3.187 by -$1.173.
Is Kala Pharmaceuticals Inc overvalued?
According to Wall Street analysts Kala Pharmaceuticals Inc’s price is currently Undervalued.
Does Kala Pharmaceuticals Inc pay dividends?
Kala Pharmaceuticals Inc does not currently pay dividends.
What is Kala Pharmaceuticals Inc’s EPS estimate?
Kala Pharmaceuticals Inc’s EPS estimate is -$3.46.
How many shares outstanding does Kala Pharmaceuticals Inc have?
Kala Pharmaceuticals Inc has 2,542,716 shares outstanding.
What happened to Kala Pharmaceuticals Inc’s price movement after its last earnings report?
Kala Pharmaceuticals Inc reported an EPS of -$4.36 in its last earnings report, missing expectations of -$3.187. Following the earnings report the stock price went down -1.603%.
Which hedge fund is a major shareholder of Kala Pharmaceuticals Inc?
Among the largest hedge funds holding Kala Pharmaceuticals Inc’s share is Baker Bros Advisors LP. It holds Kala Pharmaceuticals Inc’s shares valued at 2M.
---
Kala Pharmaceuticals Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$31.50 (204.52% Upside)
$31.50 (204.52% Upside)
Hedge Fund Trend
Increased
By 39.4K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.2%
Last 30 Days ▼ 5.1%
Last 30 Days ▼ 5.1%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-24.96%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-21.74%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Kala Pharmaceuticals Inc
Kala Pharmaceuticals, Inc. is a biopharmaceutical company. It focuses on the development and commercialization of therapeutics using proprietary nanoparticle-based Mucus Penetrating Particles, or MPP, technology, with an initial focus on the treatment of eye diseases. The company was founded by Justin Hanes, Robert S. Langer and Colin R. Gardner in 2009 and is headquartered in Watertown, MA.
---
Top 5 ETFs holding KALA
iShares Core S&P Total U.S. Stock Market ETF
$92.88
Up to five ETFs with an Outperform Smart Score that hold KALA. The ETFs are listed according to market value of KALA within the ETF
---